FolioLanternBeta
MRNAModerna

Abbas Hussain

Director at Moderna, as of May 8, 2026Sold $279K of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
34%†
share of stake sold at Moderna
† Measured against shares held at the start plus shares received, because most of the shares sold arrived during the period.
12K
shares held after the latest filing, Moderna
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
2
companies filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDec 2025: $14K under a disclosed planDecJanFebMarAprMay 2026: $265K under a disclosed plan$265KMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Moderna (MRNA)DirectorOct 4, 2024May 8, 2026
Teva Pharmaceutical Industries Ltd (TEVA)Former DirectorSep 3, 2020Jun 16, 2021

Also a director at

Teva Pharmaceutical Industries Ltd (TEVA) (no filing in the last 18 months)

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.